Cargando…
Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
Cannabis sativa and its extracts have been used for centuries, both medicinally and recreationally. There is accumulating evidence that exogenous cannabis and related cannabinoids improve symptoms associated with inflammatory bowel disease [IBD], such as pain, loss of appetite, and diarrhoea. In viv...
Autores principales: | Ambrose, Tim, Simmons, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441301/ https://www.ncbi.nlm.nih.gov/pubmed/30418525 http://dx.doi.org/10.1093/ecco-jcc/jjy185 |
Ejemplares similares
-
Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016) -
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
por: Kwan Cheung, Keith A., et al.
Publicado: (2019) -
The Endocannabinoid System, Cannabinoids, and Pain
por: Fine, Perry G., et al.
Publicado: (2013) -
Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease
por: Corridoni, Daniele, et al.
Publicado: (2018) -
Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies
por: Duncan, R. Scott, et al.
Publicado: (2023)